Paper Presentations and Guest Lectures

  • At  ASPCR CME, Riyadh 2008

    At ASPCR CME, Riyadh 2008

    ‘Management of lip vitiligo by autologous melanocyte transplantation’ at ACSICON 2008 and SAARC Conference of Cutaneous Surgeons held in Indore, India

  • Guest speaker at 3rd International Symposium for Vitiligo in Combination with 2nd CME Asian Society for Pigment Cell Research held in Riyadh, Saudi Arabia.
  • ‘New modified procedure of non cultured autologous melanocyte transplantation in stable vitiligo’ at DERMACON 2009 held in Bengaluru, India.
  • ‘New modified procedure of melanocyte transplantation for “Difficult to treat “ vitiligo lesions’ at ICD 2009 held in Prague, Czech Republic.
  • ‘Phosphate buffered saline as an effective alternate to melanocyte media in autologous non cultured melanocyte transplantation’ at 89th Annual BAD Meeting held in Glasgow, UK
  • “Retrograde migration of melanocytes in the improvement of Leukotrichia: Role of epidermal suspension transplantation as a link between hypothesis and theory.” at 4th Asian Society for Pigment Cell Research meeting held in Guangzhou, China.
  • ”Non cultured epidermal suspension transplantation: Its journey beyond special needs” at Fortis Hiranandani Hospital, Vashi, Navi Mumbai in August 2010.
  • “Is the success of autologous non cultured epidermal suspension transplantation depends on the special medium like melanocyte medium?” at First Vitiligo World Congress held in Milan, Italy .
  • Guest lecture on non cultured epidermal suspension transplantation and what’s new in vitiligo at Mauritius in December 2010.
  • Guest Lecture on “Factors affecting the outcome of non cultured epidermal suspension transplantation” at Delhi IADVL meeting in March 2011
  • Faculty for vitiligo surgery workshop conducted at VITILICON 2011 held in Bangalore in April 2011.
  • ”Milligrafting: a novel way of melanocyte transplantion in stable vitiligo” at World Congress of Dermatology held in Seoul, Korea in May 2011
  • “Combination surgery: When stable lesion rather than stable disease is an inclusion criteria for the surgical management of vitiligo” as a poster presentation at 91st Annual meeting of BAD held in London in July 2011.
  • Panelist in the panel discussion on vitiligo surgery at 5th ASPCR meeting in New Delhi in November 2012.